Pfizer
Tamara Morocco has over 25 years of work experience in the pharmaceutical and clinical research industry. Tamara started their career as a Research Associate at John B. Pierce Laboratory in 1992. Tamara then worked as a Clinical Data Project Manager at Kendle International from 1998 to 2004. From 2004 to 2012, they held various roles at Pfizer, Inc, including Study Manager and Associate Director of Program Study Management. Tamara then joined Covance in 2012 as a Senior Project Manager in Early Clinical Development. In 2014, they returned to Pfizer as a Director of Clinical Operations Study Team Lead, and later became a Senior Director and Clinical Program Team Lead. Throughout their career, they have gained expertise in clinical operations, project management, and leadership.
Tamara Morocco earned their Bachelor of Science degree in Sports Medicine from the University of Connecticut, where they attended from 1986 to 1990. Tamara then went on to pursue a Master's degree in Physiology, also at the University of Connecticut, from 1990 to 1994.
This person is not in any offices
Pfizer
606 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.